Neurology Grand Rounds: Donanemab, and Other Updates to Anti-Amyloid Therapy, for the Treatment of Early Alzheimer’s disease
Andrew Natonson, M.D., M.S., Assistant Professor, Neurology Residency Program Director, Director Alzheimer’s Amyloid Clinic, Division of Aging, Alzheimer’s and Related Disorders & Division of Comprehensive Neurology, Department of Neurology, OHSU
When |
Wednesday, February 5, 2025
8 to 9 a.m. PST
|
---|---|
Where |
Campus:
Building:
3245 SW Pavilion Loop
Portland,
Oregon
97239
4248
|
Contact Information |
Virtual
View the live stream, or join us through our Webex meeting link, starting at 7:50 a.m. Wednesday
- Live stream: stream the meeting
- Webex meeting: use this link if you plan to participate in the Q & A session. Ask your questions in the chat window.